{
  "item1": "section within MD&A COMMERCIAL OPERATIONS manage commercial operations through global structure consisting three operating segments, each led single manager: Biopharma, PC1 Pfizer Ignite. Biopharma, innovative science-based biopharmaceutical business, engaged discovery, development, manufacture, marketing, sale distribution biopharmaceutical products worldwide. PC1 contract development manufacturing organization leading supplier specialty active pharmaceutical ingredients. Pfizer Ignite offering provides strategic guidance end-to-end R&D services select innovative biotech companies align R&D focus areas.",
  "item7": null,
  "item2": "––The cost availability financing influenced credit ratings, increase decrease credit rating could beneficial adverse effect financing. long-term debt rated high-quality both S&P Moody’s. NAME RATING AGENCY Pfizer Short-Term Rating Pfizer Long-Term Rating P-1 A2 S&P A-1 These ratings not recommendations buy, sell hold securities ratings subject revision withdrawal any time rating organizations. Each rating should evaluated independently any other rating."
}